Reportedly, exPKM2 can activate the epidermal growth factor receptor (EGFR) signaling pathway in cancer cells19,20, and EGFR ligands, including EGF and transforming growth factor-α, can enhance bone resorption31. Here, EGFR is linked to cancer.